Three years ago, while filming short videos explaining European Inhibitor Network, we were looking forward with great hope for treatment options for people with inhibitors to finally become available, after years of very limited choice.

What is available today for people with inhibitors would have not been possible without all those who took part in clinical trials!

According to the European Principles of Inhibitor Management, improvements in clinical outcomes for inhibitor patients increasingly depend on future research and innovation. Clinical trials are an essential part of this process. This is true not only for inhibitor patients, but also in other rare bleeding disorders with scarce treatment options.

Check out the latest information about ongoing clinical trials, also available through a direct link on the EHC website (under “Bleeding Disorders”)!!